- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| PROMIMIC Aktie jetzt für 0€ handeln | |||||
| 06.05. | Curiteva & Promimic - Bonded by Innovation | 98 | ACCESS Newswire | HUNTSVILLE, ALABAMA / ACCESS Newswire / May 6, 2025 / Curiteva, a leader in 3D-printed Trabecular PEEK implant technology, is pleased to announce an expanded partnership with Promimic, pioneers in nanotechnology... ► Artikel lesen | |
| 18.02. | Karolinska Development AB (publ): Karolinska Developments portfolio company Promimic publishes positive results on reduction of bacteria growth on HAnano Surface | 159 | GlobeNewswire (Europe) | STOCKHOLM, SWEDEN, February 18 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Promimic has published positive results showing a reduction of bacterial... ► Artikel lesen |
2 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 78,00 | -0,03 % | Medtronic Begins U.S. Trial Of Onyx LES For Peripheral Arterial Hemorrhage | DUBLIN (dpa-AFX) - Medtronic (MDT) has announced the enrollment of the first patient in its PELE (PEripheral Onyx Liquid Embolic) clinical trial, which will evaluate the safety and efficacy... ► Artikel lesen | |
| HCA HEALTHCARE | 301,10 | +0,80 % | Aktie von HCA läuft heute schlechter (297,6416 €) | Am US-amerikanischen Aktienmarkt liegt der Anteilsschein von HCA zur Stunde im Minus. Die Aktie notiert derzeit bei 349,58 US-Dollar. Die Aktie von HCA verzeichnet aktuell ein Minus von 4,11 Prozent.... ► Artikel lesen | |
| LANTHEUS | 60,76 | -1,30 % | Lantheus Holdings, Inc.: Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D | BEDFORD, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH), today announced the successful completion of its previously disclosed acquisition... ► Artikel lesen | |
| AMEDISYS | 82,00 | -0,61 % | Amedisys Q1 Profit Increases, Beats Estimates | WASHINGTON (dpa-AFX) - Amedisys (AMED) announced earnings for its first quarter that increased from the same period last year and beat the Street estimates.The company's bottom line totaled... ► Artikel lesen | |
| ENVISTA | 16,400 | -0,61 % | Envista Holdings Corp - 8-K, Current Report | ||
| CAREDX | 10,985 | -0,81 % | CareDx rebounds as draft LCD suggests no change in coverage | ||
| SYNEOS HEALTH | - | - | Research Solutions, Inc.: Research Solutions Reports Fiscal Third Quarter 2025 Results | Reports 23 Percent Increase in ARR to $20.4 Million and 43 Net New Platform Deployments, Positive Net Income and Record Adjusted EBITDA and Cashflow
HENDERSON... ► Artikel lesen | |
| GT BIOPHARMA | 1,985 | -0,75 % | GT Biopharma, Inc.: GT Biopharma Advances GTB-3650 Phase 1 Trial to Cohort 2 Following Successful Initial Human Dosing and Evidence of Early Immune Activation Signals |
Following the formal safety review of Cohort 1, no safety or tolerability issues were observed, allowing the company to move forward with Cohort 2. The company plans on releasing more detailed results... ► Artikel lesen | |
| CARMAT | 0,281 | -6,49 % | CARMAT Announces the Initiation of a Call for Public Tenders (Buyers or Investors) as Part of the Receivership Procedure | Regulatory News:
CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from... ► Artikel lesen | |
| CHEMOMETEC | 68,50 | +1,03 % | Chemometec A/S: Preliminary revenue figures for the 2024/25 financial year | ANNOUNCEMENT NO. 290 1 July 2025 Preliminary revenue figures for the 2024/25 financial year Based on the preliminary financial figures, ChemoMetec now expects revenue of around DKK 496 million... ► Artikel lesen | |
| ARRAIL GROUP | 0,248 | -3,12 % | ARRAIL GROUP (06639): CONNECTED TRANSACTION IN RELATION TO AMENDMENT TO THE LOAN AGREEMENT AND PLEDGE OF SHARES BY THE CONTROLLING SHAREHOLDER | ||
| POLAREAN IMAGING | 0,016 | 0,00 % | Polarean Imaging PLC - Promotion & sales representative agreement | ||
| DEVYSER DIAGNOSTICS | 12,760 | +9,62 % | Devyser Diagnostics AB: Devyser Diagnostics AB publishes quarterly report for the period April to June 2025 | "A positive operating result was recorded in the second quarter. The effects of the cost-cutting program initiated at the beginning of the year can already be seen in both current costs and in the cost... ► Artikel lesen | |
| FRESENIUS | 41,720 | +2,36 % | Aktie von Fresenius SE & Co. KGaA heute am Aktienmarkt kaum gefragt: Kurs fällt (41,21 €) | An der deutschen Börse notiert die Fresenius SE & Co. KGaA-Aktie derzeit ein wenig leichter. Die Aktie notiert zur Stunde bei 41,21 Euro. Der Anteilsschein von Fresenius+Co KgaA verzeichnet aktuell... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 45,680 | -0,26 % | Silber wird zum Rüstungsmetall: Silver North Resources, Rheinmetall, Siemens Healthineers | Das Ultimatum von US-Präsident Donald Trump an Russland ist noch keine vier Tage alt, da ist schon absehbar, dass es ohne Reaktion bleiben wird. Russland setzt seine Angriffe auf die Ukraine fort und... ► Artikel lesen |
PROMIMIC AB gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 1,540 Euro und damit -4,35 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PROMIMIC AB finden Sie auf Wallstreet Online.